Who We Serve
We support management teams, boards, and sponsors across life sciences and healthcare at critical strategic inflection points.
ClarityNorth Partners works with capitalized biopharma, MedTech and diagnostics, healthcare technology and AI, and life-sciences services companies. We support leaders navigating capital events, partnerships, acquisitions, divestitures, carve-outs, integrations, and portfolio decisions where additional senior corporate-development and execution capacity is required.
Investors & Capital Allocators
We work with investors deploying capital across the life sciences and healthcare sector, including venture capital, growth equity, private equity, and family offices. We help investors understand not only what a company has built, but how it can scale, partner, and ultimately become a successful strategic asset.
Innovators, Operators & Strategics
We support founders, leadership teams, and corporate development groups across biotech, medtech, diagnostics, and healthcare platforms as they navigate growth and transition. Our role is to align scientific innovation with commercial strategy and capital expectations.
Our Sector Focus Areas
Biotech & Therapeutics
Small molecules, biologics, rare disease, oncology, CNS
Advanced Therapies
Cell therapy, gene therapy, RNA and regenerative medicine
MedTech & Devices
Surgical technologies, implantables, monitoring and device platforms
AI & Digital Health
Data platforms, clinical software, AI-enabled healthcare tools
Diagnostics & Precision Medicine
Biomarkers, molecular diagnostics, clinical testing platforms
Healthcare Systems & Services
Care delivery, provider networks, and healthcare platforms
Specialty Chemicals & Manufacturing
Materials, reagents, and ingredients supporting therapeutics and devices
Tools & Services
CROs, CDMOs, research tools and laboratory services
Inflection Points We Support: Before, During & After the Transaction
We support life sciences and healthcare companies when strategic decisions, transactions, and operating change become too important to manage through existing capacity alone.
​
Our work spans the corporate-development lifecycle, from capital readiness and strategic alternatives through transaction execution, separation, integration, and value creation.
Capital Readiness
Strategic Alternatives
Partnering & Licensing
M&A Execution
Carve-Out & Day 1
Integration & Day 100
Value Creation & Exit
Working With Both Builders and Backers
How We Engage Both Sides of the Market
We work on both the company side and the investor or buyer side of the market. This dual perspective allows us to help each party understand how decisions are evaluated across the table, improving fundraising, partnerships, and transaction outcomes.
​
We believe better alignment between innovators and capital produces stronger companies and more durable strategic outcomes.
Global Reach
Our work is inherently international. Life sciences and healthcare companies build globally and capital moves across borders. We regularly support clients and transactions across North America and Europe, and collaborate with partners in additional markets.
Case Snapshots
